Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis.

Lee YY, Mok MT, Kang W, Yang W, Tang W, Wu F, Xu L, Yan M, Yu Z, Lee SD, Tong JHM, Cheung YS, Lai PBS, Yu DY, Wang Q, Wong GLH, Chan AM, Yip KY, To KF, Cheng ASL.

Nucleic Acids Res. 2018 Sep 28;46(17):8832-8847. doi: 10.1093/nar/gky589.

2.

Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver.

Merkulova TI, Kropachev KY, Timofeeva OA, Vasiliev GV, Levashova ZB, Ilnitskaya SI, Kobzev VF, Pakharukova MY, Bryzgalov LO, Kaledin VI.

Mol Carcinog. 2005 Dec;44(4):223-32.

PMID:
16267830
3.

Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors.

Lazarevich NL, Cheremnova OA, Varga EV, Ovchinnikov DA, Kudrjavtseva EI, Morozova OV, Fleishman DI, Engelhardt NV, Duncan SA.

Hepatology. 2004 Apr;39(4):1038-47.

PMID:
15057908
4.
5.
6.

Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours.

Kalkuhl A, Kaestner K, Buchmann A, Schwarz M.

Carcinogenesis. 1996 Mar;17(3):609-12.

PMID:
8631153
7.

Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes.

O'Brien RM, Noisin EL, Suwanichkul A, Yamasaki T, Lucas PC, Wang JC, Powell DR, Granner DK.

Mol Cell Biol. 1995 Mar;15(3):1747-58.

Supplemental Content

Loading ...
Support Center